Joshua
De Leon received his B.A. in Biology and Philosophy from Franklin and Marshall
College in 1984 and his M.D. from SUNY Downstate School of Medicine in 1988. He
completed a residency in internal medicine and a fellowship in clinical and
molecular cardiology at the Albert Einstein College of Medicine and is
currently an Associate Professor of Medicine and Director of Cardiovascular
Research at NYU Long Island School of Medicine. Dr. De Leon is a practicing
cardiologist with extensive clinical experience in managing patients with
inflammatory mechanisms underlying their cardiovascular disease and patients
with disordered lipid metabolism. He is also a biomedical researcher who works
closely with Dr. Reiss in conducting basic and translational studies to
elucidate the cellular and molecular mechanisms underlying acute coronary
syndromes, as well as the more chronic processes that promote atherogenesis. He
has been a co-investigator on an American Heart Association-funded study of
inflammation in cardiovascular disease and has participated as a site
investigator for multiple clinical trials addressing acute coronary syndromes,
chronic CAD management, and lipid metabolism/management. He has many well-cited
publications, many co-authored with Dr. Reiss.
Research Keywords & Expertise
Atherosclerosis
Cardiovascular
Cholesterol metabolism
acute coronary syndrom...
Fingerprints
47%
Cardiovascular
24%
Atherosclerosis
5%
Cholesterol metabolism
Short Biography
Joshua
De Leon received his B.A. in Biology and Philosophy from Franklin and Marshall
College in 1984 and his M.D. from SUNY Downstate School of Medicine in 1988. He
completed a residency in internal medicine and a fellowship in clinical and
molecular cardiology at the Albert Einstein College of Medicine and is
currently an Associate Professor of Medicine and Director of Cardiovascular
Research at NYU Long Island School of Medicine. Dr. De Leon is a practicing
cardiologist with extensive clinical experience in managing patients with
inflammatory mechanisms underlying their cardiovascular disease and patients
with disordered lipid metabolism. He is also a biomedical researcher who works
closely with Dr. Reiss in conducting basic and translational studies to
elucidate the cellular and molecular mechanisms underlying acute coronary
syndromes, as well as the more chronic processes that promote atherogenesis. He
has been a co-investigator on an American Heart Association-funded study of
inflammation in cardiovascular disease and has participated as a site
investigator for multiple clinical trials addressing acute coronary syndromes,
chronic CAD management, and lipid metabolism/management. He has many well-cited
publications, many co-authored with Dr. Reiss.